Kinetic study of the inflammatory response in Streptococcus pneumoniae experimental pneumonia treated with the ketolide HMR 3004

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 1, 2001, Pages 252-262

  Duong, M ^a   Simard, M ^a   Bergeron, Y ^a   Bergeron, M G ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

KETOLIDE; NITRIC OXIDE;

ANIMAL MODEL; ARTICLE; CHRONOLOGY; DEATH; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; LUNG PARENCHYMA; MALE; MONOCYTE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SHOCK; STREPTOCOCCUS PNEUMONIAE; TISSUE INJURY;

ANIMALS; ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; INFLAMMATION; INTERLEUKIN-6; KETOLIDES; LUNG; MACROLIDES; MALE; MICE; NEUTROPHILS; NITRIC OXIDE; PEROXIDASE; PHAGOCYTES; PNEUMOCOCCAL INFECTIONS; PULMONARY EDEMA; STREPTOCOCCUS PNEUMONIAE; SURVIVAL ANALYSIS;

EID: 0035165625     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.1.252-262.2001     Document Type: Article

References (27)

1. Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogens
2. Community-acquired pneumonia in adults: Guidelines for management
3. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice
4. Why does pneumococcus kill?
5. Compartmentalized cytokine production within the human lung in unilateral pneumonia
6. Immunomodulating effects of HMR 3004 on pulmonary inflammation caused by heat-killed Streptococcus pneumoniae in mice
7. Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents
8. NO contest: Nitric oxide plays complex roles in infection
9. Pulmonary and systemic inflammatory responses in rabbits with gram-negative pneumonia
10. Nitrate synthesis in the germfree and conventional rat
11. Nitric oxide: Pathophysiological mechanisms
12. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004
13. Inflammatory mediators, cytokines and adhesion molecules in pulmonary inflammation and injury
14. The role of nitric oxide in inflammation
15. Phagocyte function and cytokine production in community-acquired pneumonia
16. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: A population-based study
17. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain
18. Ketolide treatment of Haemophilus influenzae experimental pneumonia
19. Patterns of cytokine expression in community-acquired pneumonia
20. In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany
21. In vitro activity of RU 64004, a new ketolide antibiotic, against grampositive bacteria
22. Macrophage and polymorphonuclear neutrophils in lung defense and injury
23. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia
24. Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils
25. Adult bacteremic pneumococcal pneumonia in a community hospital, 1992-1996
26. Protective and pathological roles of nitric oxide in endotoxin shock
27. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory response